Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001596771-16-000107
Filing Date
2016-04-27
Accepted
2016-04-27 13:56:53
Documents
1
Effectiveness Date
2016-04-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 14292
  Complete submission text file 0001596771-16-000107.txt   15437
Mailing Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-245322 | Film No.: 161594595
SIC: 2834 Pharmaceutical Preparations